Clinical outcomes of single-visit oral prophylaxis : a practice-based randomised controlled trial by Jones, Clare L et al.
RESEARCH ARTICLE Open Access
Clinical Outcomes of Single-Visit Oral Prophylaxis:
A Practice-based Randomised Controlled Trial
Clare L Jones1*, Keith M Milsom1,2, Philip Ratcliffe3, Annette Wyllie4, Tatiana V Macfarlane5 and Martin Tickle1
Abstract
Background: Practice-based general dental practitioners routinely provide “scale and polish” or “oral prophylaxis”
to patients attending their practices. Despite its routine provision, there is no evidence to support the clinical
effectiveness of single-visit scale and polish, nor the frequency at which it should be provided. A recent systematic
review recommended that future trials investigating scale and polish should involve dental practice patients.
Methods: A practice-based parallel randomised controlled trial with 24-month follow-up was conducted. Healthy
adults (Basic Periodontal Examination [BPE] codes <3) were randomly assigned to 3 groups (6-month, 12-month, or
24-month interval between scale and polish). The primary outcome was gingival bleeding with the hypothesis that
6-monthly scale and polish would result in lower prevalence than 12-month or 24-month frequency. Follow-up
measurements were recorded by examiners blinded to the allocation. 125, 122 and 122 participants were
randomised to the 6-month, 12-month and 24-month groups respectively. Complete data set analyses were
conducted for 307 participants: 107, 100, and 100 in the 6-month, 12-month and 24-month groups respectively.
Chi-square test and ANOVA were used to compare treatment groups at follow-up. Logistic regression and ANCOVA
were used to estimate the relationship between outcome and treatment group, adjusted for baseline values.
Multiple imputation analyses were also carried out for participants with incomplete data sets.
Results: Prevalence of gingival bleeding at follow-up was 78.5% (6-month), 78% (12-month) and 82% (24-month)
(p = 0.746). There were no statistically significant differences between groups with respect to follow-up prevalence
of plaque and calculus. Statistically significant differences detected in the amount (millimetres) of calculus were too
small to be clinically significant. Seventeen (4.6%) participants were withdrawn from the trial to receive additional
treatment.
Conclusions: This trial could not identify any differences in outcomes for single-visit scale and polish provided at
6, 12 and 24 month frequencies for healthy patients (with no significant periodontal disease). However, this is the
first trial of scale and polish which has been conducted in a general practice setting and the results are not
conclusive. Larger trials with more comprehensive measurement and long-term follow up need to be undertaken
to provide a firm evidence base for this intervention. This trial informs the design of future practice-based trials on
this subject.
Background
General dental practitioners (GDPs) routinely recom-
mend and provide “scale and polish” or “oral prophy-
laxis” to patients attending their practices [1,2]. This
single-visit treatment consists of supra- and sub-gingival
scaling to remove hard deposits, and polishing the teeth
with a powered cup, or brush, and paste.
Different definitions of the term ‘routine scale and
polish’ exist and its role in the management of period-
ontal disease is not specifically defined [3]. Scale and
polish is intended to complement patients’ self-care pla-
que-control methods and historically has become inex-
tricably linked to the routine (six-monthly) dental
check-up, even if a patient has no, or low, risk of devel-
oping periodontal disease [2-5]. Oral hygiene instruction
may be provided in conjunction with the scale and pol-
ish to encourage positive oral health behaviour change
and improved self-care; furthermore, it has been
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suggested that there is little value to the professional
intervention if hygiene advice is not given [6].
Provision of single-visit scale and polish incurs costs
for privately-paying patients and for tax-payers in pub-
licly-funded healthcare systems. It is unclear what pro-
portion of this treatment is clinically necessary [7], yet
in 2009/10, 12 million (44.1% of total) courses of treat-
ment carried out on adult National Health Service
(NHS) patients in England included a scale and polish
[1].
Despite its routine provision, there is a debate regard-
ing the clinical effectiveness of single-visit scale and pol-
ish, and the frequency at which it should be provided. A
systematic literature review [3] was unable to reach firm
conclusions about the beneficial effects on periodontal
health and recommended (practice-based) randomised
controlled trials (RCTs) to investigate the effectiveness
of the intervention.
This paper reports the findings of a preliminary RCT
which aimed to compare gingival health outcomes of
single-visit scale and polish, performed at 6-, 12- or 24-
month intervals, in healthy adults, with no significant
periodontal disease who were regular attenders at
‘family’ dental practices. The objectives were to compare
presence of gingival bleeding, dental plaque, and amount
of calculus between groups receiving single-visit scale
and polish at these intervals.
Methods
The trial protocol responded to recommendations [3]
and was reviewed and approved by Cheshire Local
Research Ethics Committee (reference: Q/1506/100.)
The trial was registered with UKCRN: (ID5101); and
ISRCTN (ISRCTN56889016). The Oral Health Unit at
The University of Manchester funded the trial. Research
support costs were met by Cheshire and Merseyside
Comprehensive Research Network (funded by the
National Institute for Health Research.)
The study was a randomised, 3-arm, parallel clinical
trial with an allocation ratio of 1. The follow-up period
was 24 months; the maximum period advised between
dental check-ups by national guidelines [8].
Participants
Participants were recruited from three multi-surgery
family dental practices in Northwest England that had
sufficient estate space and large patient populations,
enabling them to host the trial. Regularly-attending
patients aged 18-60 years who were scheduled for a den-
tal check-up were sent an appointment for a dedicated
trial recruitment session with written information about
the trial i.e. specific days/sessions were set aside for trial
recruitment rather than patients being recruited on an
ad hoc basis when they attended for their routine dental
appointment. On attendance the trial was discussed
with patients and informed, written consent was
obtained by a member of the research team. Participants
were free to withdraw from the trial at any time, with-
out explanation.
Eligibility checks were carried out by the patients’ own
GDPs using standardised pro forma and by two inde-
pendent trial examiners. The latter were registered den-
tists who worked in the salaried dental services and who
had no connection to the trial practices. Full details of
the inclusion criteria are presented in Figure 1. The
principal exclusion criteria were BPE code 3/4/* (see
Additional File 1) in one or more sextants [9] and evi-
dence of systemic periodontal risk factors [10]. It was
thought that confining the inclusion criteria to non-
smokers may have compromised recruitment given that
it is not an uncommon habit. Smokers were therefore
not excluded as long as they fulfilled the eligibility
criteria.
Sample Size & Randomisation
Data available to inform the sample size calculation was
limited. A pragmatic approach was taken and a suite of
power calculations was carried out with advice from a
specialist in periodontology (see Additional File 2).
Assuming 20% loss to follow-up 369 participants were
required to achieve a sample size of 96 per group at fol-
low-up. This was sufficient to detect a clinically signifi-
cant difference in proportions of bleeding (power 90%;
a = 0.01) assuming a 30% bleeding rate in the 6-month
group, 45% in the 12-month group and 60% in the 24-
month group.
Baseline assessment was undertaken by the two inde-
pendent trial examiners prior to randomization of the
369 recruited participants to ensure allocation conceal-
ment. This examination also enabled participants to be
stratified according to presence/absence of supra-gingi-
val calculus prior to randomization. Treatment alloca-
tion was by minimization [11] and carried out by the
trial manager using MINIM, an MS-DOS program [12].
Participants’ group allocation was not revealed until
they returned for their first 6-month recall; they were
informed of this by the hygienist providing the trial
intervention. Participants’ family dentists were blind to
intervention allocation in as much as this was not
revealed by the research team; participants were asked
not to disclose their allocation group to their dentist or
to the outcome examiner. The same two examiners car-
ried out all of the follow-up examinations blind to the
allocation.
Interventions
Single-visit scale and polish treatments were carried out
by 9 hygienists and therapists employed by the dental
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practices. All had appropriate professional qualifications,
and were registered with the UK professional regulatory
body (General Dental Council.) A standard definition of
single-visit scale and polish [3] was adopted: hygienists
and therapists were instructed to carry out supra- and
subgingival scaling, or polishing, or both, of the crown
and root surfaces of teeth to achieve an end-point of no
deposits and/or staining. There was no adjunctive root
planing or chemotherapeutic therapy and local anaes-
thetic was not used. An ultrasonic scaler and an air
Eligible patients:
Were not involved in any concurrent study which could affect the parameters being 
investigated in this trial
Were aged 18-60 years at the time of recruitment
Were regular dental attenders who had previously had a single-visit scale and polish
Had BPE sextant codes less than 3 (i.e. code 0, 1, or 2)
Did not, in the opinion of their family dental practitioner, require more extensive periodontal 
therapy
Did not require antibiotic prophylaxis prior to single-visit scale and polish
Had a minimum 20 natural teeth (these could be crowned)
Had less than four actively decayed teeth (i.e. excluded if DT>3)
Did not have a fixed or removable orthodontic appliance, a removable prosthetic 
appliance, or a removable acrylic splint
Were generally fit and well, with no systemic conditions or medication that could 
predispose periodontal disease e.g.
o Diabetes Mellitus
o Hereditary Gingival Fibromatosis
o Von Recklinghausen’s Disease (Neurofibromatosis I)
o Neutrophil impairments e.g.
 Agranulocytosis
 Cyclic neutropenia
 Lazy leukocyte syndrome
 Chediak-Higashi syndrome
 Downs Syndrome
 Papillon-Lefevre syndrome
 Chronic granulomatous disease
o Drug Therapies e.g.
 Phenytoin
 Cyclosporin
 Ca channel blockers e.g. Nifedipine
 Sodium Valproate
 Prednisolone
 Long term NSAID therapy
 Chemotherapy
o Immunosuppressive conditions including HIV/AIDS
o Leukaemia
o Post-head-&-neck-carcinoma irradiation
o Pregnancy/Lactating females
o Rheumatoid Arthritis
Figure 1 Participant Trial Inclusion Criteria.
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motor-driven rotary rubber cup with polishing paste
were used unless participants were unable to tolerate
ultrasonic instrumentation; in such cases, hand-scaling
was performed.
All participants received a baseline single-visit scale
and polish after baseline assessment. Throughout the
24-month follow-up period, all participants were
recalled every 6-months for routine examination with
their family dentist which included monitoring of their
periodontal condition using BPE [9,13]. If practitioners
had concerns about a participant’s periodontal condi-
tion, they were referred to one of the two independent
trial examiners. If the independent trial examiner
detected a BPE code 3, this led to the participant being
withdrawn from the trial to receive appropriate treat-
ment. At baseline and at each subsequent 6-monthly
appointment all participants received standardised oral
hygiene advice from a hygienist [14]; (See Additional
File 3.) The same hygienist delivered the intervention:
the 6-month group received a single-visit scale and
polish at 6, 12, and 18-months; the 12-month group
received single-visit scale and polish at 12-months.
The 24-month group received no scale and polish
interventions after baseline for the duration of the
trial. Participants were allocated 15-20 minute appoint-
ments for oral hygiene advice plus intervention; how-
ever, additional time was permitted, as required, to
complete the intervention within a single-visit. A dia-
grammatical representation of the trial is provided in
Figures 2, 3, 4.
The hygienist trial record sheets were reviewed at the
end of each session. If a participant was scheduled to
have a scale and polish at a recall session had erro-
neously not received this, every effort was made to con-
tact them to arrange another appointment so that this
could be delivered.
Outcomes
The primary outcome measure was presence of gingival
bleeding (dichotomous); secondary outcomes were pre-
sence of plaque (dichotomous), presence (dichotomous)
and amount (millimetres) of calculus.
Outcome measurements were taken at baseline and
24-month follow-up by two independent examiners. The
baseline examination was undertaken before the delivery
of the baseline scale and polish. The outcome measure-
ments were taken before the participants saw their own
family dentist for a check up and provision of any scal-
ing and polishing deemed necessary i.e. measurements
were taken approximately 6 months after the 18-month
intervention. Both examiners were experienced in exam-
ining for national epidemiological studies [15]. For the
purposes of this trial, they undertook training (See Addi-
tional File 4) in the examination procedure prior to
baseline and follow-up examinations. The following
information was recorded for each participant:
• Bleeding from the gingival margin of six (Ramf-
jord) index teeth [16,17]. Bleeding was detected by
running a blunt-ended (PCP-10) probe gently
around the gingival margin of the tooth at a 60°
angle, in contact with the sulculur epithelium. After
approximately 30 seconds, any bleeding elicited was
recorded according to a dichotomous scale for each
tooth: present/not present.
• Visual presence of any plaque on the same index
teeth according to a dichotomous scale: plaque pre-
sent/not present.
• Measurement of calculus in millimetres: One mea-
surement, confined to the lingual surfaces of the
mandibular incisor and canine teeth. A PCP-10
probe was used to measure along the vertical axis of
the tooth with the most calculus.
Analysis
Statistical analysis was conducted by the trial statistician
(TM) blind to the allocation, i.e. the treatment groups
were coded without disclosing the labelling. PASW Sta-
tistics 18 [18] and STATA [19] were used for data
analysis.
Demographic baseline characteristics were described.
Hypothesis testing of baseline imbalance is not recom-
mended practice and, therefore, was not performed
[20-22]
Complete case analysis was carried out initially. Inten-
tion to treat (ITT) analysis [23] was not possible as
100% follow-up was not achieved. To minimise bias
caused by missing data, multiple imputation was
employed for participants with incomplete datasets [24].
A Chi-square test was used to compare dichotomous
data in treatment groups at follow-up: prevalence (pre-
sence) of any bleeding, any plaque and any calculus by
participant (rather than by tooth). The proportion of
teeth with bleeding at follow-up was calculated as the
total number of teeth with any bleeding divided by the
total number of teeth examined for bleeding. The pro-
portion of teeth with plaque at follow-up was calculated
in a similar manner. An analysis of variance (ANOVA)
was used to compare treatment groups at follow-up for:
• proportion of teeth with bleeding;
• proportion of teeth with plaque; and
• mean amount (millimetres) of calculus.
Logistic regression and ANCOVA were used to esti-
mate the relationship between outcome and treatment
group, adjusted for the baseline values.
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Multiple imputation (n = 100 imputations) was per-
formed using mi logit and mi mvn procedures in
STATA [19]. Variables used in imputation were: base-
line values, gender, baseline age, deprivation score and
randomization group. Deprivation was calculated using
the Index of Multiple Deprivation; a small area measure
derived from participants’ residential postcodes [25].
The 6-month group represented traditional frequency of
scale and polish and was used as the reference group to
which other groups were compared.
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Figure 2 RCT CONSORT flow diagram (Recruitment, Baseline, 6 months).
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Results
The CONSORT flow diagram [20] is presented in Fig-
ures 2, 3, 4. There were 40 dedicated recruitment ses-
sions 02/2006 to 09/2007. Of the 826 patients
approached, 44.7% (N = 369) consented, and were ran-
domly allocated to a trial group. Of the 369 participants
commencing the trial, 3 were found to have been
recruited in error and did not fulfil the inclusion
criteria. Seventeen participants chose to discontinue the
trial (5 from 6-month group, 4 from 12-month group,
and 8 from 24-month group.) Two participants were
withdrawn by their family dentist and a further fifteen
were withdrawn from the trial by the independent trial
examiners due to concerns that they had a BPE code of
3 (Total 17: 6 from 6-month group; 4 from 12-month
group; 9 from 24-month group.). Follow-up data were
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Figure 3 RCT CONSORT flow diagram (12 months, 18 months).
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Figure 4 RCT CONSORT flow diagram (24-month follow-up, Analysis).
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collected for 83.5% of the original participants; 76.2%
attended all 5 trial appointments. Baseline demographic
and clinical characteristics of trial participants are pre-
sented in Table 1.
Prevalence of gingival bleeding increased in all groups
between baseline and follow-up (Table 2). There were
no significant differences between groups at follow-up
(P = 0.746). Odds ratios, adjusted for baseline bleeding,
showed no significant association between frequency of
scale and polish and bleeding prevalence.
There were no significant differences between groups
at follow-up with respect to prevalence of plaque (P =
0.183) and calculus (P = 0.615) (Table 3).
The mean amount (height) of calculus present on the
lower anterior teeth at follow-up was: 6-month group
0.71 mm (SD 1.00); 12-month group 0.89 mm (SD
Table 1 Baseline demographic and clinical characteristics of trial participants
Characteristic 6-month Group 12-month Group 24-month Group
Baseline No. of Participants 125 122 122
Age (years)
Mean (SD) 37.1 (10.4) 39.6 (10.8) 36.4 (10.6)
Gender
N (%) Male 57 (45.6) 43 (35.2) 34 (27.9)
IMD Quintilea
N (%)
1 Most Deprived 40 (32.0) 40 (32.8) 34 (27.9)
2 29 (23.2) 29 (23.8) 30 (24.6)
3 18 (14.4) 18 (14.8) 24 (19.7)
4 24 (19.2) 21 (17.2) 21 (17.2)
5 Least Deprived 14 (11.2) 14 (11.5) 13 (10.7)
Smoking historyb
N (%)
Never 83 (66.4) 70 (57.4) 71 (58.2)
Past 21 (16.8) 31 (25.4) 29 (23.8)
Current 12 (9.6) 15 (12.3) 15 (12.3)
Missing 8 6 7
No. of Teeth present
Mean (SD) 27.8 (2.4) 27.8 (2.1) 27.6 (2.3)
Missing 0 1 0
Decayed Teeth
N (%) any 9 (37.5) 8 (33.3) 7 (29.2)
Missing 0 1 0
Filled Teeth
Mean (SD) 7.7 (4.5) 7.7 (4.7) 6.8 (4.3)
Missing 0 1 0
Baseline clinical data for participants attending both baseline and follow up examinations
Bleeding prevalence N = 307
N(%) with any bleeding 54 (50.5) 63 (63.0) 65 (65.0)
Proportion of index teeth with bleeding N = 307
Mean (SD) 17.4 (21.6) 21.2 (21.0) 21.5 (21.5)
Plaque prevalence N = 307
N (%) with any plaque 81 (75.7) 79 (79.0) 77 (77.0)
Calculus prevalence N = 305
N (%)with any calculus 64 (60.4) 53 (53.5) 52 (52.0)
Amount Calculus (mm) N = 305
Mean (SD) 0.79 (0.77) 0.80 (0.94) 0.72 (0.83)
aIMD derived from participants’ postcodes. Quintiles based on national standards.
bSelf reported smoking status based upon response to the following questions: Do you currently smoke? (yes/no); Have you ever smoked? (yes/no) For
participants recruited 02/2006 - 09/2006 these data were reported retrospectively, at the 12-month recall. For patients recruited 2007, smoking data were
reported at baseline.
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0.99); 24-month group 0.95 mm (SD 0.97). Adjustment
of follow-up calculus for baseline measures showed this
difference to be statistically significant (ANCOVA p =
0.001).
The results of the multiple imputation analysis were
similar to the complete dataset analysis: no additional
statistically significant differences were identified.
Ancillary analyses examined the proportion of index
teeth with bleeding or plaque. All groups demonstrated
increased prevalence in bleeding from baseline to fol-
low-up. Follow up proportions of teeth with bleeding
(Table 2), were 37.9% (SD 30.3) in 6-month group;
38.8% (SD 30.7) in 12-month group; 39.8% (SD 30.2) in
24-month group. These proportions were not signifi-
cantly different between groups (ANCOVA p = 0.979)
Follow-up proportions of teeth with plaque were
39.4% (SD 34.1), 43.0% (SD 34.9), and 43.7% (SD 32.4)
in the 6-month, 12-month and 24-month groups respec-
tively. Differences between groups were not significant
(ANCOVA P = 0.597.)
Discussion
This is the first randomised control trial in the literature
investigating the effectiveness of scale and polish when
it is delivered in a general practice setting. It should
therefore be seen as the first stepping stone to improve
the evidence-base for this commonly provided interven-
tion rather than providing definitive evidence to inform
policy on resource allocation or as a basis for clinical
guidelines. This was a pragmatic trial, involving healthy
adult participants with no significant periodontal dis-
ease, who had a history of regularly visiting their family
dental practitioner. It was not an explanatory trial and
did not investigate an intervention performed on
patients with periodontal disease or under specialist
care. Over a 24-month follow-up period, the researchers
could not detect a statistically or clinically significant
difference in gingival health measures between groups.
The difference in the amount of supragingival calculus
between groups was statistically significant yet too small
to be clinically significant, given that it is unlikely that it
could be detected clinically by family dentists using the
instruments commonly used in general dental practice.
Prevalence of plaque at baseline (and follow-up) was
comparable to findings of national epidemiological sur-
veys [26]. This suggests that the trial has reasonable
external validity and that even in a motivated population
presence of plaque is the ‘norm’. The overall increase in
the primary outcome measure trial across the whole
trial population gives cause for concern. One interpreta-
tion of this finding could be that it is due to a real dete-
rioration in gingival health across all three groups.
Furthermore this decline could be attributed to sub-
optimal delivery of the scale and polish. This could well
be the case, but equally the dental care professionals
(hygienists and therapists) could have striven to provide
a more thorough scale and polish than usual. Knowing
that their work would be independently assessed, it
could be argued that this latter scenario is more likely
than providing sub-optimal care. In pragmatic trials
Table 2 Effect of Scale and Polish on Gingival Bleeding
6-month Group 12-month Group 24-month Group Statistical Test
Prevalence of gingival bleeding
Data available for both baseline and follow up (N = 307) 107 100 100
N (%) with any bleeding at follow-up 84 (78.5) 78 (78.0) 82 (82.0) Χ2 test
P = 0.746
Complete data analysis (N = 307)
Odds Ratio (from Logistic regression)
(95% CI) for follow up adjusted for baseline bleeding
1.00 0.92
(0.47, 1.79)
1.17
(0.59, 2.35)
Multiple imputation analysisc (N = 368)
Odds Ratio (from Logistic regression)
(95% CI) for follow up adjusted for baseline bleeding
1.00 0.92
(0.45, 1.89)
1.19
(0.58, 2.47)
Proportion of index teeth examined with gingival bleedingd
Complete data analysis (N = 307)
Follow-up % of index teeth with bleeding
Mean (SD)
37.9 (30.3) 38.8 (30.7) 39.8 (30.2) ANOVA P = 0.896
Follow-up % of index teeth with bleeding adjusted for baseline bleeding ANCOVA P = 0.979
Multiple imputation analysisc (N = 368)
Follow-up % of index teeth with bleeding adjusted for baseline bleeding
(from linear regression)
P = 0.932
cFollow-up data were imputed using baseline values, gender, age at baseline, deprivation score and randomization group.
dThe percent of index teeth with bleeding was calculated for each participant as the total number of teeth with bleeding over the total number of index teeth
examined.
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there will be greater variation in the delivery of the
intervention under test than is the case for explanatory
trials and therefore the intervention is less likely to be
effective. In addition, for interventions for which the
practitioner cannot be blinded to the allocation, as is
the case in many trials of surgical interventions, there
will always be the risk of a Hawthorne effect [27] result-
ing in the intervention under test being not truly repre-
sentative of the intervention as it is provided in ‘real
life’. In this trial participants were monitored by their
‘family dentist’ every 6 months and dental practitioners
could refer participants giving cause for concern to an
independent examiner who was blind to the allocation.
A small number of patients were referred and a smaller
number removed from the trial because of clinical con-
cerns. This and the relative stability of plaque scores
between baseline and follow up suggest that inter exam-
iner variation in probing force used to assess gingival
bleeding is a more likely to account for the increase in
bleeding on probing rather than an overall deterioration
in gingival health of the trial population. This interpre-
tation is supported by analyses which demonstrate that
examiner 1 assessed more patients at baseline and
examiner 2 assessed more patients at follow up (Table
4). The overall increase in bleeding could be explained
by examiner 2 using a consistently greater probing force
than examiner 1. However there were no significant dif-
ferences in the distribution of participants examined by
Table 3 Effect of Scale and Polish on Plaque and Calculus
6-month Group 12-month Group 24-month Group Statistical Test
Prevalence of plaque
Data available for both baseline and follow up (n = 307)
N (%) with any plaque at follow-up 79 (73.8) 76 (76.0) 84 (84.0) Χ2 test
P = 0.183
Complete data analysis (N = 307)
Odds Ratio (from Logistic regression)
(95% CI) for follow up adjusted for baseline plaque
1.00 1.08
(0.57, 2.07)
1.89
(0.93, 3.81)
Multiple imputation analysis* (N = 368)
Odds Ratio (from Logistic regression)
(95% CI) for follow up adjusted for baseline plaque
1.00 1.04
(0.54, 1.98)
1.90
(0.93, 3.86)
Proportion of index teeth with plaque. Data available for both baseline and follow-up (N = 307)
Follow-up % of index teeth with plaque
Mean (SD)
39.4 (34.2) 43.5 (34.7) 43.7 (32.4) ANOVA P = 0.587
Follow-up % of index teeth with plaque adjusted for baseline plaque ANCOVA P = 0.597
Multiple imputation analysis* (N = 368)
Follow-up % of index teeth with plaque adjusted for baseline values (from linear regression) P = 0.653
Prevalence of lingual calculus
Data available for both baseline and follow up (N = 305)
N (%) with any calculus at follow-up 59 (55.7) 54 (54.5) 61 (61.0) Χ2 test
P = 0.615
Complete data analysis (N = 305)
Odds Ratio (from Logistic regression)
(95% CI) for follow up adjusted for baseline calculus
1.00 1.10
(0.60, 2.04)
1.58
(0.85, 2.95)
Multiple imputation analysis* (N = 367)
Odds Ratio (from Logistic regression)
(95% CI) for follow up adjusted for baseline calculus
1.00 1.12
(0.60, 2.09)
1.64
(0.86, 3.13)
Amount (mm) of lingual calculus
Data available for both baseline and follow up (N = 305)
Follow-up Calculus
Mean (SD)
0.71 (1.00) 0.89 (0.99) 0.95 (0.97) ANOVA P = 0.022
Mean difference (95% CI)
6-24: -0.32 (-0.61, -0.02)
6-12: -0.26 (-0.55, 0.04)
24-12: 0.06 (-0.24, 0.36)
Follow up Calculus adjusted for baseline calculus ANCOVA P = 0.001
Multiple imputation analysis (N = 367)
Follow-up Calculus adjusted for Baseline values (from linear regression) P < 0.001
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the two examiners at baseline and follow up across the
three arms of the study and therefore inter-examiner
variation would have a minimal influence on the
between-group findings.
Significant barriers to executing research in general
practice have been reported [28,29], and were experi-
enced in the operational management of this trial. Lack
of empirical data on the expected effect size to inform a
power calculation meant that the sample size was based
on estimates according to clinical expectations and an
ability to identify an effect size which would influence
clinicians to consider changing their clinical practise,
Recruitment of participants was logistically difficult and
caused considerable disruption to day-to-day running of
the dental practices, potentially effecting practice
income; for this reason clinical measurement was lim-
ited and recruitment ceased once the trial had achieved
its recruitment target. A larger sample size would have
resulted in tighter confidence intervals and the authors
acknowledge that a longer follow-up period would have
been desirable; a 5-year period [3] was initially proposed
but a compromise (2-year follow-up) was reached in
response to concern expressed by family dentists about
withholding treatment for such a long period. On a
positive note, participant loss to follow-up was low (less
than 20%) and this preliminary trial demonstrates that
dental practices and dental patients can be successfully
recruited to practice based trials; with significantly
greater resources larger sample sizes and longer follow
up periods would be possible.
Interpretation of trials with non-significant findings is
difficult, particularly for preliminary trials because bias
tending towards a non-significant result can stem from
different sources. The potential for allocation bias was
considered to be small as the trial manager had no
knowledge of the patients other than the basic details
required for randomization. Baseline imbalances there-
fore occurred by chance rather than allocation bias; the
magnitude of chance imbalance was not considered to
be clinically significant. The 24-month group had a
lower proportion of males than other groups, but gender
is not a significant risk for periodontal disease progres-
sion [30]; and similar proportions of males and females
were lost to follow up. Whilst smoking is a risk factor
for periodontal disease, smokers were included if they
fulfilled the eligibility criteria. The randomisation pro-
cess ensured that smokers were evenly distributed
between groups. Subgroup analysis of the smokers was
not undertaken due to the small numbers and because
inadequately powered post hoc analyses can produce
misleading results [31]. Future trials on this topic may
wish to confine the trial population to smokers or
power the trial to enable well designed sub-group
analyses.
Pragmatic trials vs. explanatory trials
This was a pragmatic trial i.e. one which primarily seeks
to determine the effects of an intervention under the
usual conditions in which it will be applied; in contrast,
explanatory trials are primarily designed to determine
the effects of an intervention under ideal circumstances
[32]. The continuum between explanatory trials and
pragmatic trials is very helpfully examined by Thorpe et
al. [33] who identify variation in practitioner adherence
to applying the intervention (discussed above), and
patient compliance with the intervention as factors
which reduce the effect size of interventions tested in
pragmatic trial. Pragmatic trials also tend to have greater
flexibility in eligibility criteria, (usually far less stringent
than explanatory trials), less intensive follow up and
greater flexibility in applying the experimental and com-
parison interventions. As a consequence a smaller effect
size or even a non-significant result is a more likely
finding in pragmatic trials than explanatory trials
because of the ‘noise’ around the process of delivery of
the intervention. This means that future pragmatic trials
in this field will require much larger numbers to detect
the ‘signal’ of the intervention delivered in a real world
practice setting.
There were also issues around the outcome measures
used in this trial. Guidance suggests that periodontitis is
best assessed long-term by measuring attachment levels,
but cautions that any change less than 2 mm could be
due to measurement error [34]. It must be remembered
that the trial population consisted of patients without
significant periodontal disease (BPE < 3) who attend
family dental practices on a regular basis; the measures
used were chosen as they are simple clinical indicators
Table 4 Distribution of examiners at baseline and follow-up by treatment group
Characteristic 6-month Group
N (%)
12-month Group
N (%)
24-month Group
N (%)
Statistical Analysis
Baseline and Follow-up
both examiner 1
28 (26.2) 25 (25.0) 27 (27.0) Χ2 test
P = 0.995
Baseline and Follow-up
both examiner 2
10 (9.3) 9 (9.0) 10 (10.0)
Baseline examiner 1;
Follow-up examiner 2
69 (64.5) 66 (66.0) 63 (63.0)
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which would prompt action by a GDP and change the
care plan for patients [4]. The same two experienced
examiners were used at both baseline and follow up,
and both received the same extensive training by a spe-
cialist periodontologist prior to baseline and follow-up
examinations. However, there was the possibility of
inter-examiner variation as it was not possible to cali-
brate examiners given the invasive nature of the exami-
nation. The trial reflects the tensions felt, particularly in
pragmatic trials, between using very precise, interval
scale measures which increase the power of trials, and
using dichotomised outcomes which decrease power but
are intuitively more meaningful to GDPs and patients.
So the measures used in this preliminary trial were lim-
ited and in future trials a more comprehensive approach
to outcome measurement should be used. Trialists
working in the dental field should consider how to
reach a consensus on trial outcome measures perhaps
under the COMET (Core Outcome Measures in Effec-
tiveness Trials) Initiative [35] which seeks to obtain con-
sistency in the choice of outcome measures for trials.
However, in this field there would still be concerns
about inter examiner reliability particularly in very large
pragmatic trials with multiple examiners.
Whilst the trial participants were asked not to reveal
their group allocation, evidently, there was potential for
them to inform the independent examiners. Further-
more, it is possible that participants’ clinical appearance
may have been indicative of trial group. This is acknowl-
edged as a limitation of the trial; and whilst one could
argue that bias due to inadequate allocation conceal-
ment in this trial would work in the direction of finding
a significant difference between groups, this risk should
be minimised in the design of trials and through careful
management. Questioning examiners to determine
whether they could identify group allocation may have
enabled researchers to identify bias with respect to
reporting outcome measurements [36].
One source of bias which could tend to a non-signifi-
cant finding is the possibility that group allocation could
have selectively affected loss to follow-up. In this trial
there was greater loss to follow-up in the 24-month
group than the 12- and 6-month groups, although the
difference in numbers was small (The proportions of
original participants who attended 24-month follow-up
were: 85.6% 6-month group; 82.8% 12-month group;
82.0% 24-month group.) Selective loss to follow-up is
always a potential problem for pragmatic, non-blinded
trials as patients are likely to have a preference for the
‘usual’ treatment (a commonly used control in prag-
matic trials) or for a new treatment under test. The
potential for which way the bias is directed (towards a
significant or a non-significant finding) is, we suspect,
specific to each trial. A parallel qualitative component of
the trial design to assess participant’s views of the rela-
tive merits of experimental and comparison interven-
tions may be helpful in assessing the risk of bias of
selective loss to follow up.
There is no single indicator which accurately predicts
healthy patients’ risk of periodontal disease. Chronic
gingivitis [37], smoking, poor oral hygiene, and being
over 65 years of age [38] are all predictors. It could be
argued that routine 6-monthly scale and polish repre-
sents a practice-based population approach to prevent-
ing periodontal disease. However, if there really is no
difference in gingival health outcomes when this inter-
vention is provided less frequently, routine 6-monthly
treatment for low risk patients is difficult to support. It
should be remembered that routine provision of scale
and polish for healthy patients has opportunity costs for
state-funded healthcare systems i.e. time which could be
spent performing more clinically effective treatments.
This may not be sustainable in the current economic
climate. There are also issues with respect to informed
decision making for privately-paying patients with no
significant periodontal disease. However this trial is pre-
liminary and therefore cannot provide firm evidence to
inform policy or clinical practise.
The importance of oral hygiene instruction in con-
junction with scale and polish delivery was not investi-
gated in this RCT. There is some evidence from non-
practice based trials which suggests that the professional
intervention to remove plaque in conjunction with oral
hygiene instruction is as effective as oral hygiene
instruction on its own; and that both of these are more
beneficial than no treatment at all [6]. This however is a
different research question than the one asked in this
trial, which was concerned with frequency of scale and
polish delivery. A larger sample size is required to inves-
tigate groups receiving scale and polish at different fre-
quencies with or without oral hygiene advice, and the
constraints of this trial meant that this was not feasible.
There is therefore a further requirement for future prac-
tice-based research to investigate the contributions of
scale and polish and oral hygiene instruction to period-
ontal health alone and in combination. Two of the
authors (CJ, MT) are involved with just such a practice-
based trial which will seek to unpick this relationship
[39].
Conclusions
Single-visit scale and polish is a treatment historically
embedded in general dental practice rather than being a
defined treatment for periodontal disease. The question
of whether or not routinely providing a 6-monthly sin-
gle-visit scale and polish is an effective use of profes-
sional resources for healthy adults with no significant
periodontal disease cannot be answered by the first
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practice-based trial in the literature. This preliminary
trial does not provide sufficient evidence to support or
refute the benefit of 6-month scale and polish over 12-
or 24-month treatment provision; it does however raise
important questions and will inform the design and con-
duct of further pragmatic practice-based trials which
seek to investigate this subject.
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